Tags

Type your tag names separated by a space and hit enter

Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Heart. 2005 Aug; 91(8):1080-5.H

Abstract

BACKGROUND

It is well known that angiotensin converting enzyme (ACE) inhibitors and angiotensin II type 1 (AT1) receptor blockers (ARBs) prevent left ventricular (LV) remodelling after myocardial infarction (MI). However, it is still not clear whether inhibition of the AT1 receptor is enough to prevent LV remodelling after MI.

OBJECTIVE

To elucidate the effects of ACE inhibitors that are not mediated by the AT1 receptor on LV remodelling, MI was experimentally induced in wild-type (WT-MI) mice and AT1 receptor knockout (KO-MI) mice.

METHODS

Mice were divided into six groups: WT-control, KO-control, WT-MI, KO-MI, WT-MI treated with an ACE inhibitor, and KO-MI treated with an ACE inhibitor. Four weeks after MI, cardiac function was assessed by Doppler echocardiography and non-infarcted myocardial mRNA expression by northern blot analysis.

RESULTS

Cardiac function decreased significantly in the MI groups compared with the sham operated groups. Additionally, in the MI groups end diastolic dimension, E wave velocity, the ratio of peak velocity of E wave to A wave, deceleration rate of E wave, and mRNA expression of atrial natriuretic peptide, brain natriuretic peptide, and collagens I and III increased significantly compared with the sham groups. LV remodelling after MI was prevented in KO-MI mice compared with WT-MI mice. ACE inhibitor administration significantly attenuated progressive LV remodelling in both WT and KO-MI groups.

CONCLUSION

ACE inhibitors can prevent the LV remodelling process that accompanies cardiac dysfunction after MI, even in AT1 KO mice. These findings suggest that ACE inhibitors prevent LV remodelling after MI by mechanisms other than inhibition of angiotensin AT1 receptor mediated effects.

Authors+Show Affiliations

Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University, Osaka, Japan. yoshiyama@med.osaka-cu.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16020603

Citation

Yoshiyama, M, et al. "Angiotensin Converting Enzyme Inhibitor Prevents Left Ventricular Remodelling After Myocardial Infarction in Angiotensin II Type 1 Receptor Knockout Mice." Heart (British Cardiac Society), vol. 91, no. 8, 2005, pp. 1080-5.
Yoshiyama M, Nakamura Y, Omura T, et al. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. Heart. 2005;91(8):1080-5.
Yoshiyama, M., Nakamura, Y., Omura, T., Izumi, Y., Matsumoto, R., Oda, S., Takeuchi, K., Kim, S., Iwao, H., & Yoshikawa, J. (2005). Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. Heart (British Cardiac Society), 91(8), 1080-5.
Yoshiyama M, et al. Angiotensin Converting Enzyme Inhibitor Prevents Left Ventricular Remodelling After Myocardial Infarction in Angiotensin II Type 1 Receptor Knockout Mice. Heart. 2005;91(8):1080-5. PubMed PMID: 16020603.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. AU - Yoshiyama,M, AU - Nakamura,Y, AU - Omura,T, AU - Izumi,Y, AU - Matsumoto,R, AU - Oda,S, AU - Takeuchi,K, AU - Kim,S, AU - Iwao,H, AU - Yoshikawa,J, PY - 2005/7/16/pubmed PY - 2005/8/23/medline PY - 2005/7/16/entrez SP - 1080 EP - 5 JF - Heart (British Cardiac Society) JO - Heart VL - 91 IS - 8 N2 - BACKGROUND: It is well known that angiotensin converting enzyme (ACE) inhibitors and angiotensin II type 1 (AT1) receptor blockers (ARBs) prevent left ventricular (LV) remodelling after myocardial infarction (MI). However, it is still not clear whether inhibition of the AT1 receptor is enough to prevent LV remodelling after MI. OBJECTIVE: To elucidate the effects of ACE inhibitors that are not mediated by the AT1 receptor on LV remodelling, MI was experimentally induced in wild-type (WT-MI) mice and AT1 receptor knockout (KO-MI) mice. METHODS: Mice were divided into six groups: WT-control, KO-control, WT-MI, KO-MI, WT-MI treated with an ACE inhibitor, and KO-MI treated with an ACE inhibitor. Four weeks after MI, cardiac function was assessed by Doppler echocardiography and non-infarcted myocardial mRNA expression by northern blot analysis. RESULTS: Cardiac function decreased significantly in the MI groups compared with the sham operated groups. Additionally, in the MI groups end diastolic dimension, E wave velocity, the ratio of peak velocity of E wave to A wave, deceleration rate of E wave, and mRNA expression of atrial natriuretic peptide, brain natriuretic peptide, and collagens I and III increased significantly compared with the sham groups. LV remodelling after MI was prevented in KO-MI mice compared with WT-MI mice. ACE inhibitor administration significantly attenuated progressive LV remodelling in both WT and KO-MI groups. CONCLUSION: ACE inhibitors can prevent the LV remodelling process that accompanies cardiac dysfunction after MI, even in AT1 KO mice. These findings suggest that ACE inhibitors prevent LV remodelling after MI by mechanisms other than inhibition of angiotensin AT1 receptor mediated effects. SN - 1468-201X UR - https://www.unboundmedicine.com/medline/citation/16020603/Angiotensin_converting_enzyme_inhibitor_prevents_left_ventricular_remodelling_after_myocardial_infarction_in_angiotensin_II_type_1_receptor_knockout_mice_ L2 - https://heart.bmj.com/lookup/pmidlookup?view=long&pmid=16020603 DB - PRIME DP - Unbound Medicine ER -